关注
Michele Klain
Michele Klain
Dipartimento di Scienze Biomediche Avanzate, Università degli Studi di Napoli Federico II
在 unina.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Subclinical hyperthyroidism: clinical features and treatment options
B Biondi, EA Palmieri, M Klain, M Schlumberger, S Filetti, G Lombardi
European Journal of Endocrinology 152 (1), 1-9, 2005
3512005
Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma
A Bachelot, AF Cailleux, M Klain, E Baudin, M Ricard, N Bellon, B Caillou, ...
Thyroid 12 (8), 707-711, 2002
2272002
Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status
L Tauchmanova, R Pivonello, C Di Somma, R Rossi, MC De Martino, ...
The Journal of Clinical Endocrinology & Metabolism 91 (5), 1779-1784, 2006
1602006
The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses
S Maurea, M Klain, C Mainolfi, M Ziviello, M Salvatore
Journal of Nuclear Medicine 42 (6), 884-892, 2001
1602001
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males
C Di Somma, A Colao, A Di Sarno, M Klain, ML Landi, G Facciolli, ...
The Journal of Clinical Endocrinology & Metabolism 83 (3), 807-813, 1998
1531998
Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization
A Colao, C Di Somma, S Loche, A Di Sarno, M Klain, R Pivonello, ...
Clinical Endocrinology 52 (3), 319-327, 2000
1412000
Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study
C Di Somma, R Pivonello, S Loche, A Faggiano, M Klain, M Salvatore, ...
Clinical Endocrinology 58 (3), 302-308, 2003
1312003
Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease
C Di Somma, A Colao, R Pivonello, M Klain, A Faggiano, FS Tripodi, ...
Clinical Endocrinology 48 (5), 655-662, 1998
1071998
Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases
G Storto, M Klain, G Paone, R Liuzzi, L Molino, A Marinelli, A Soricelli, ...
Bone 39 (1), 35-41, 2006
1052006
Effects of dietary treatment on bone mineral density in adults with celiac disease: factors predicting response.
C Ciacci, L Maurelli, M Klain, G Savino, M Salvatore, G Mazzacca, ...
American Journal of Gastroenterology (Springer Nature) 92 (6), 1997
1011997
Radioiodine therapy for papillary and follicular thyroid carcinoma
M Klain, M Ricard, S Leboulleux, E Baudin, M Schlumberger
European Journal of Nuclear Medicine and Molecular Imaging 29, S479-S485, 2002
932002
Radioactive iodine-refractory differentiated thyroid cancer: an uncommon but challenging situation
A Schmidt, L Iglesias, M Klain, F Pitoia, MJ Schlumberger
Archives of endocrinology and metabolism 61, 81-89, 2017
912017
Total thyroidectomy, without prophylactic central lymph node dissection, in the treatment of differentiated thyroid cancer. Clinical retrospective study on 221 cases
G Conzo, D Pasquali, G Bellastella, K Esposito, C Carella, A De Bellis, ...
Endocrine 44, 419-425, 2013
842013
Severe impairment of bone mass and turnover in Cushing’s disease: comparison between childhood‐onset and adulthood‐onset disease
C Di Somma, R Pivonello, S Loche, A Faggiano, P Marzullo, A Di Sarno, ...
Clinical Endocrinology 56 (2), 153-158, 2002
822002
Treatment of refractory thyroid cancer
A Berdelou, L Lamartina, M Klain, S Leboulleux, M Schlumberger
Endocrine-related cancer 25 (4), R209-R223, 2018
802018
The use of recombinant human TSH in the follow‐up of differentiated thyroid cancer: experience from a large patient cohort in a single centre
V Giovanni, LG Arianna, C Antonio, F Francesco, K Michele, S Giovanni, ...
Clinical Endocrinology 56 (2), 247-252, 2002
782002
Combined evaluation of regional coronary artery calcium and myocardial perfusion by 82Rb PET/CT in the identification of obstructive coronary artery disease
E Zampella, W Acampa, R Assante, C Nappi, V Gaudieri, CG Mainolfi, ...
European journal of nuclear medicine and molecular imaging 45, 521-529, 2018
652018
Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and 131I ablation
B Salvatore, G Paone, M Klain, G Storto, E Nicolai, D D'Amico, ...
QJ Nucl Med Mol Imaging 52 (1), 2, 2008
532008
Diagnostic accuracy of radionuclide imaging using 131I nor-cholesterol or meta-iodobenzylguanidine in patients with hypersecreting or non-hypersecreting adrenal tumours
S Maurea, M Klain, C Caraco, M Ziviello, M Salvatore
Nuclear medicine communications 23 (10), 951-960, 2002
502002
Impairment of bone status in patients with central diabetes insipidus
R Pivonello, A Colao, C Di Somma, G Facciolli, M Klain, A Faggiano, ...
The Journal of Clinical Endocrinology & Metabolism 83 (7), 2275-2280, 1998
471998
系统目前无法执行此操作,请稍后再试。
文章 1–20